Sacituzumab Govitecan-Hziy (Trodelvy™)

{"title":"Sacituzumab Govitecan-Hziy (Trodelvy™)","authors":"Jennifer Hedgecorth","doi":"10.1097/01.COT.0000749876.89266.8F","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19642,"journal":{"name":"Oncology Times UK","volume":"3 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-04-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Times UK","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.COT.0000749876.89266.8F","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}